Majestic: Boston Scientific reveals 9-month Eluvia data for PAD

Boston Scientific reveals 9-month data from the Majestic trial of its Eluvia stent for treating peripheral artery disease.

Boston Scientific, Charing Cross International Symposium

News Well, Clinical Trials, Peripheral Artery Disease

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1EOs94p